Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Down - What's Next?

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. (NASDAQ:MDRX) saw its share price gap down from a previous close of $4.83 to an opening price of $4.60, last trading at $4.65 with a volume of 2,192 shares.
  • Wall Street analysts have given Veradigm a "hold" rating, as coverage was initiated by Wall Street Zen.
  • The company's 50-day moving average is $4.53, while the 200-day moving average is $5.12, showing a downward trend.
  • Veradigm is a healthcare technology company providing IT solutions and services including electronic health records, analytics, and population health management.
  • Five stocks to consider instead of Veradigm.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $4.83, but opened at $4.60. Veradigm shares last traded at $4.65, with a volume of 2,192 shares.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen initiated coverage on Veradigm in a research note on Tuesday, May 20th. They issued a "hold" rating on the stock.

Check Out Our Latest Stock Report on MDRX

Veradigm Price Performance

The business has a 50 day moving average price of $4.53 and a 200 day moving average price of $5.12.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines